Tocilizumab as a targeted immunomodulatory therapy in the management of severe respiratory illnesses: a multicenter cohort study of COVID-19 patients
Al Mutair$n$ et al., Scientific Reports, doi:10.1038/s41598-025-08638-3
https://c19early.org/almutair2.html